Plasma 25-Hydroxyvitamin D(3) and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study

BACKGROUND: Previous evidence suggests that 25-hydroxyvitamin D(3) [25(OH)D(3)] protects against several cancers. However, little is known regarding urothelial bladder cancer (UBC). We analyzed the association between plasma 25(OH)D(3) and overall risk of UBC, as well as according to stage and FGFR3...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Amaral, André FS, Méndez-Pertuz, Marinela, Muñoz, Alberto, Silverman, Debra T., Allory, Yves, Kogevinas, Manolis, Lloreta, Josep, Rothman, Nathaniel, Carrato, Alfredo, Rivas del Fresno, Manuel, Real, Francisco X., Malats, Núria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3525815/
https://ncbi.nlm.nih.gov/pubmed/23108201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs444
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak